Related Articles
EFFECT OF TUMOR SIZE ON THE ASSOCIATION BETWEEN PS2 AND CATHEPSIN-D IN PRIMARY BREAST-CANCER
Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors
Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients
P(185/HER2) AND PS2 PROTEIN OVEREXPRESSION IN BREAST-CANCER SPECIMENS - IMPROVEMENT FOR PREDICTION OF RESPONSE TO ENDOCRINE THERAPY
QUANTITATIVE IMAGING OF PS2 IMMUNOCYTOCHEMICAL ASSAYS IN BREAST CARCINOMAS